Guidant Agrees to Buyout Plan; Johnson & Johnson Will Acquire the Heart Device Maker for $21.5 Billion

Summary


INDIANAPOLIS (AP) - Johnson & Johnson said Tuesday it agreed to acquire Guidant Corp. for $21.5 billion in cash and stock under a revised deal that values the troubled maker of implantable heart care devices at about $4 billion less than last year's original pact.

Under the revised agreement that likely ends a legal showdown between the two companies, health care products maker Johnson & Johnson will buy Indianapolis-based Guidant for about $63.08 per share, down from December's original offer of $25.4 billion, or about $76 a share.

See the full content of this document

Extract


Guidant Agrees to Buyout Plan; Johnson & Johnson Will Acquire the Heart Device Maker for $21.5 Billion

"It appropriately reflects the business challenges we have experi...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company